Skip to main content
Login
User menu
Mega menu
EASL.eu
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Genetic Grand Round
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - EASL Congress
Industry Symposia - EASL Liver Cancer Summit
Industry Symposia - EASL SLD Summit
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 288
(current)
Session 275
Displaying 277 - 288 of 288
Display:
12
24
48
Cirrhosis & Complications
Serum albumin concentration matters: on-treatment target albumin levels and outcomes
Webcasts
View
Cirrhosis & Complications
Albumin mechanism of action supporting dosage strategy
Webcasts
View
Cirrhosis & Complications
Discussion and Q&A
Webcasts
View
Cirrhosis & Complications
Welcome and introduction
Webcasts
View
Cirrhosis & Complications
The role of albumin in liver cirrhosis: the mechanism behind the clinical evidence
Webcasts
View
Cirrhosis & Complications
The clinical effect of long-term albumin administration: a disease-modifying strategy in cirrhosis?
Webcasts
View
Cirrhosis & Complications
The cost-effectiveness of albumin in decompensated cirrhosis: a worthy investment
Webcasts
View
Cirrhosis & Complications
Q&A’s / Discussion
Webcasts
View
Cirrhosis & Complications
Conclusions and end of Symposium
Webcasts
View
Immune-Mediated and Cholestatic Diseases
PFIC: Genotype-Phenotype Implications for Diagnosis
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Course of Disease and Potential Novel Therapeutic Options in the Management of Patients With PFIC
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Current page
24
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy